Diabetic Neuropathic Pain: Gabapentin vs. Pregabalin vs. Duloxetine vs. Oxcarbazepine – Which one Wins?

MONTHLY INSIGHT SESSION #5

In our 5th monthly Insight Session, Dr. Harvinder Singh has provide a concise summary of clinically relevant findings on five key topics based on recently published articles and updates:
 
(1) WOMEN’S MENTAL HEALTH:
  • Is Methylphenidate & Atomoxetine safe in Pregnancy?
(2) ANXIETY DISORDER:
  • Role of D-Cycloserine during exposure sessions in Agoraphobia.
(3) PSYCHOPHARMACOLOGY & MEDICAL CONDITIONS:
  • Which one is preferred for diabetic peripheral neuropathy: Gabapentin, Pregabalin, Oxcarbazepine or Duloxetine?
(4) ADHD:
  • Understaning Viloxazine Response Trajectories in ADHD treatment
(5) FDA UPDATES:
  • FDA panel Voted Against Clozapine REMS
 
The following video is a small section from this Monthly Insight session:

Diabetic Neuropathic Pain: Gabapentin vs. Pregabalin vs. Duloxetine vs. Oxcarbazepine – Which one Wins?

This video is a summary of network meta-analysis comparing efficacy and safety of gabapentin, pregabalin, oxcarbazepine, and duloxetine in diabetic peripheral neuropathy. (Perspect Clin Res. 2024 Jul 10;15(4):202–208.)

FOR ACADEMY MEMBERS:

The complete recording of Monthly Insight session with the presentation slides are uploaded below:

ACADEMY LIVE SESSION #5

VIDEO & PRESENTATION SLIDES
ACADEMY

INTERESTED IN ACCESS TO THIS & OTHER CLINICALLY RELEVANT LECTURE SERIES?

JOIN ACADEMY MEMBERSHIP:

This is a closed membership for medical professionals only.

  • 400+ Clinically Relevant Chapters: Each chapter within these sections is of direct clinical relevance for your daily practice. (Table of Content)
  • Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice. (Read Content)
  • Clinical Case Discussion: Dr. Singh (Psychiatry) and Dr. Kaur (Family Medicine) discuss clinical cases to integrate the clinical cases from Psychiatry and Medicine. (Read Content)
  • Monthly Insights: Gain access to our monthly sessions featuring the latest on recent publications, new medication approvals, FDA updates, and more. (Monthly Insights)
  • Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases. (Academy Network)
  • Goal: is to have all important clinically relevant topics in one place for ease of access.
GENERAL
$ 150/YR
  •  
STUDENTS
$ 99/YR
  •  

DISCOUNTS AVAILABLE FOR: Residents & Students ONLY.

Email us your student information (program information and way to confirm your student status) to: HSingh@PsychiatryEducationForum.com

© 2025 All Rights Reserved.

Related Articles

Responses

Your email address will not be published. Required fields are marked *